Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03349450 |
Title | DPX-Survivac and Checkpoint Inhibitor in DLBCL (SPiReL) |
Acronym | SPiReL |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Sunnybrook Health Sciences Centre |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Tom Baker Cancer Centre - Alberta Health Services | Calgary | Alberta | Canada | Details | ||
Nova Scotia Health Authority: Queen Elizabeth II Health Sciences Centre | Halifax | Nova Scotia | B3H 2Y9 | Canada | Details | |
London Health Sciences Centre | London | Ontario | N6A 5W9 | Canada | Details | |
Ottawa Hospital Research Institute | Ottawa | Ontario | Canada | Details | ||
Sunnybrook Health Sciences Centre, Odette Cancer Centre | Toronto | Ontario | M4N 3M5 | Canada | Details | |
McGill University Health Centre | Montréal | Quebec | Canada | Details |